Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 32.35
+1.45 (4.69%)
At close: Sep 2, 2026
Anya Biopharm Market Cap
Anya Biopharm has a market cap or net worth of 1.6 billion as of September 3, 2026. Its market cap has decreased by -48.90% in one year.
Market Cap
1.60B
Enterprise Value
1.28B
Revenue
13.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.35
ChartMarket Cap Chart
Since October 25, 2024, Anya Biopharm's market cap has decreased from 2.85B to 1.60B, a decrease of -44.06%. That is a compound annual growth rate of -26.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 1.53B | -34.73% |
| Dec 31, 2025 | 2.35B | 26.96% |
| Dec 31, 2024 | 1.85B | -35.20% |
| Oct 25, 2024 | 2.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taho Pharmaceuticals | 7.99B |
| Pharmasaga | 7.79B |
| TEH SENG Pharmaceutical Mfg. | 2.58B |
| Libo Pharma | 2.21B |
| Gin Hwa Biotech Incorporation | 1.96B |
| Timing Pharmaceutial | 1.74B |
| Anbogen Therapeutics | 1.73B |
| TSA International | 1.58B |